Commission Would Back Limited Expansion Of Products Covered By MDR Grace Period
Executive Summary
There has been much speculation recently over whether the European Commission is supporting a proposal to expand the range of products covered by the four-year grace period under the Medical Device Regulation. Many have urged caution at the news, but now the commission has spoken out.
You may also be interested in...
UK Medtech Ponders Post-Brexit Regulatory Future At APPG
The consensus among the UK MHRA, the national medtech industry and notified bodies remains that convergence of regulatory systems is the preferred route for the UK once it has left the EU. Meanwhile, the regulator is planning for all eventualities, as a recent parliamentary forum on the post-Brexit regulatory landscape heard.
To Ensure Continued Availability Of Self-Care Devices In Europe, EU Commission Must 'Stop The Clock' On MDR
As the implementation deadline for the European Union's Medical Devices Regulation creeps ever closer, substance-based medical devices such as nasal sprays and throat lozenges are in danger of slipping through the net of re-certification. TÜV SÜD, one of only four notified bodies to be approved for re-certification under the new rules, says the EU should "stop the clock" on implementation to ensure these products continue to be available in Europe after the deadline.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.